Maternal serum screening

April 1999
CMAJ: Canadian Medical Association Journal;4/20/99, Vol. 160 Issue 8, p1125
Academic Journal
No abstract available.


Related Articles

  • Noninvasive screening for prenatal genetic diagnosis. Simpson, J.L. // Bulletin of the World Health Organization;1995, Vol. 73 Issue 6, p799 

    Examines three different approaches to noninvasive prenatal genetic diagnosis without risk. Applicability in mass screening programs; Maternal serum screening; Possible use of ultrasonography.

  • Maternal serum screening for Down's syndrome in early pregnancy. Wald, Nicholas J.; Cuckle, Howard S.; Densem, James W.; Nanchahal, Kiran; Royston, Patrick; Chard, Tim; Haddow, James E.; Knight, George J.; Palomaki, Glenn E.; Canick, Jacob A. // BMJ: British Medical Journal (International Edition);10/8/88, Vol. 297 Issue 6653, p883 

    Examines the maternal serum screening for Down's syndrome in early pregnancy in Great Britain. Description of the syndrome; Measurement of human chronic gonadotropin concentrations; Effectiveness of the screening method.

  • Prenatal screening for trisomy 18 with free beta human chorionic gonadotrophin as a marker. Spencer, K.; Mallard, A.S.; Coombes, E.J.; Macri, J.N. // BMJ: British Medical Journal (International Edition);12/4/93, Vol. 307 Issue 6917, p1455 

    Examines the relationship between maternal serum alpha fetoprotein and free beta human chorionic gonadotrophin concentrations during pregnancies. Development of prenatal biochemical screening; Analysis on stored maternal serum from similar pregnancies; Use of maternal age and concentrations of...

  • Screening for Down's syndrome using serum alpha fetoprotein: a retrospective study indicating caution. Spencer, K.; Carpenter, P. // British Medical Journal (Clinical Research Edition);6/29/1985, Vol. 290 Issue 6486, p1940 

    Investigates the efficacy of medical screening of Down's syndrome using serum alpha fetoprotein in Great Britain. Comparison of various screening strategies; Identification of pregnancies affected by the disease; Measurement of maternal serum alpha fetoproteins.

  • Screening for Down's syndrome. Vyas, Sanjay // BMJ: British Medical Journal (International Edition);9/24/94, Vol. 309 Issue 6957, p753 

    Focuses on Down's syndrome and mental retardation. Anomalies accompanying the syndrome; Incidence of the syndrome during birth; Screening of maternal serum in assessing risk of the syndrome in pregnancy.

  • maternal serum screen.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1413 

    A definition of the term "maternal serum screen," which refers to a blood test taken to determine the presence of congenital disease in the fetus of a pregnant woman, is presented.

  • ACOG Issues Educational Bulletin on Maternal Serum Screening.  // American Family Physician;3/1/1997, Vol. 55 Issue 4, p1454 

    Presents an educational bulletin on maternal serum screening, from the American College of Obstetrician and Gynecologists. Type of information included in the bulletin; Detailed analysis of the bulletin; Contact information.

  • Family Practice International. Walling, Anne D. // American Family Physician;6/15/2000, Vol. 61 Issue 12, p3733 

    Summarizes the results of several studies on family medicine. Transmission of coxsackie B virus infection; Update on schizophrenia; Attitudes of women toward maternal serum screening.

  • Maternal serum alphafetoprotein in pregnancy and the prevention of birth defect. Harris, Rodney // British Medical Journal;5/17/1980, Vol. 280 Issue 6225, p1199 

    Focuses on the introduction of maternal serum alphafetoprotein screening programs in pregnancy. Prevention of birth defects; Impact of growth of prenatal diagnosis and selective abortion on couples; Description of alphafetoprotein.

  • Screening for Down's syndrome in the North East Thames Region. Murday, Victoria; Slack, Joan // British Medical Journal (Clinical Research Edition);11/9/1985, Vol. 291 Issue 6505, p1315 

    Examines the screening program for Down's syndrome in the North East Thames Regional Health Authority in Europe. Use of maternal serum alpha fetoprotein for screening; Risk associated with the program; Reduction of the amniocentesis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics